Covered recipient · General Payments record
MARK H SCHWAB
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2019–2024
$3,318.76
- Reported across 203 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $516.85 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $170.30 | 8 |
| PFIZER INC. | $104.74 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $72.33 | 3 |
| Abbott Laboratories | $40.28 | 2 |
| Corcept Therapeutics | $37.64 | 2 |
| Daiichi Sankyo Inc. | $36.60 | 2 |
| Amgen Inc. | $20.65 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.74 | 1 |
| Novo Nordisk AS | $16.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.41 | 05/07/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1124859933 | CMS |
| Abbott Laboratories | $23.87 | 06/21/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1124859935 | CMS |
| ABBVIE INC. | $27.75 | 01/09/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106044128 | CMS |
| ABBVIE INC. | $23.25 | 01/11/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106044130 | CMS |
| ABBVIE INC. | $13.66 | 01/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106044132 | CMS |
| ABBVIE INC. | $30.00 | 01/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106044134 | CMS |
| ABBVIE INC. | $15.83 | 02/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106044136 | CMS |
| ABBVIE INC. | $27.99 | 02/20/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106044138 | CMS |
| ABBVIE INC. | $15.08 | 02/27/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106044140 | CMS |
| ABBVIE INC. | $16.74 | 03/14/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106044142 | CMS |
| Amgen Inc. | $20.65 | 02/14/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1117377414 | CMS |
| Corcept Therapeutics | $18.25 | 05/21/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1117755881 | CMS |
| Corcept Therapeutics | $19.39 | 06/18/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1117755883 | CMS |
| Daiichi Sankyo Inc. | $13.77 | 02/29/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1089479829 | CMS |
| Daiichi Sankyo Inc. | $22.83 | 06/28/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1089479833 | CMS |
| Novartis Pharmaceuticals Corporation | $22.64 | 02/07/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1087320037 | CMS |
| Novartis Pharmaceuticals Corporation | $26.27 | 03/04/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1087320047 | CMS |
| Novartis Pharmaceuticals Corporation | $23.42 | 04/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1087320043 | CMS |
| Novo Nordisk Inc | $16.57 | 01/11/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1097527144 | CMS |
| PFIZER INC. | $25.34 | 01/17/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131573632 | CMS |
| PFIZER INC. | $22.17 | 02/13/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131545106 | CMS |
| PFIZER INC. | $14.27 | 02/22/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131630481 | CMS |
| PFIZER INC. | $20.47 | 03/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131588402 | CMS |
| PFIZER INC. | $22.49 | 03/20/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131666112 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.74 | 02/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1137670424 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.